Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Depression 4Polycystic Ovary Syndrome 2Depressive Disorder, Major 2Neoplasms 1Lymphoma, Follicular 1Hot Flashes 1Head and Neck Neoplasms 1ENT Cancer 1Breast Neoplasms 1Asthma 1

Interventions

Metformin 91Clomiphene 31Letrozole 23Inositol 19Folic Acid 11Chorionic Gonadotropin 11Exercise 10High-Intensity Interval Training 9drospirenone and ethinyl estradiol combination 8Ethinyl Estradiol 8Contraceptives, Oral 8Cholecalciferol 8cetrorelix 7Tablets 7Progesterone 7Menotropins 6follitropin alfa 5Pioglitazone 5Liraglutide 5Exenatide 5Cyproterone Acetate 5Caloric Restriction 5Vitamin D 4Triptorelin Pamoate 4Surveys and Questionnaires 4Sugars 4Spironolactone 4Glycoprotein Hormones, alpha Subunit 4Fish Oils 4Estradiol 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Polycystic Ovary Syndrome × Escitalopram × Clear all
NCT05840692 2023-05-03

The Effect of Escitalopram in PCOS

Odense University Hospital

Phase 4 Completed
40 enrolled

Polycystic Ovary Syndrome

NCT01961180 2016-05-09

The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS

Odense University Hospital

Phase 4 Completed
42 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡